Leif Gunnar Håkansson
Chief Executive Officer at CanImGuide Therapeutics AB
Leif Gunnar Håkansson active positions
Companies | Position | Start | End |
---|---|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Founder | - | - |
Career history of Leif Gunnar Håkansson
Former positions of Leif Gunnar Håkansson
Companies | Position | Start | End |
---|---|---|---|
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
University of Lund | Corporate Officer/Principal | - | - |
Training of Leif Gunnar Håkansson
University of Lund | Doctorate Degree |
Statistics
International
Sweden | 4 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |